首页> 外文学位 >Development and characterization of methotrexate loaded poly(L-lactic acid) microspheres for the treatment of rheumatoid arthritis.
【24h】

Development and characterization of methotrexate loaded poly(L-lactic acid) microspheres for the treatment of rheumatoid arthritis.

机译:甲氨蝶呤负载聚(L-乳酸)微球的开发和表征,用于治疗类风湿关节炎。

获取原文
获取原文并翻译 | 示例

摘要

Methotrexate (MTX) has shown anti-inflammatory effects in the treatment of rheumatoid arthritis. Attempts by other groups have been made to improve the efficacy and reduce toxicity by administering the drug intra-articularly, but the outcomes were not successful due to rapid clearance of the drug from the joint cavity. MTX loaded polymeric microspheres may provide a controlled release drug delivery system to maintain an effective concentration of MTX in the joint cavity. The goals were to develop MTX loaded microspheres and to determine the in vivo biodistribution and efficacy following intra-articular injection in rabbit joints. MTX loaded poly(L-lactic acid) microspheres (size range 33-110 mum) manufactured from poly(L-lactic acid) with an average molecular weight of 2000 g/mole (PLLA2k) showed good tolerability in rabbit joints. The in vitro drug release profiles of MTX loaded PLLA2k microspheres demonstrated a rapid burst phase with more than 50% of drug being released within 5 days followed by a slow release phase.; Pharmacokinetics of MTX following intra-articular injection of both 1.5 mg and 10 mg doses of either MTX solution or MTX loaded microspheres (33-110 mum) were investigated in healthy rabbits. Plasma concentration peaked at 15 min (tmax) following intra-articular injection, and the maximum plasma concentration (Cmax) for rabbits injected with MTX solution was 5 fold higher than for rabbits injected with MTX microspheres.{09}Approximately 70% of injected MTX dose was excreted in the urine of the rabbits injected with MTX solution while only 12% of the dose was excreted in the urine of the rabbits injected with MTX microspheres 24 h following intra-articular injection.; In vivo efficacy of intra-articular MTX loaded PLLA2k microspheres (33-110 mum) or MTX solution was evaluated using an antigen-induced arthritis rabbit model. Arthritis was successfully induced in the joints of rabbits with the observation of histopathological features resembling rheumatoid arthritis. Based on the degree of swelling of the knee joints and a system of scoring the pathological features of the disease, there was no significant difference between MTX solution and microspheres treated groups compared to phosphate buffered saline (control) animals. The lack of therapeutic responses to MTX loaded microspheres treatment was likely due to the severity of the disease induced and insufficient length of the observation period.; MTX loaded PLLA2k microspheres were shown to be well tolerated in the rabbit knee joints and provide a controlled, localized delivery of MTX into the joint cavity following intra-articular injection.
机译:甲氨蝶呤(MTX)在类风湿关节炎的治疗中显示出抗炎作用。已经进行了其他小组的尝试以通过关节内施用药物来改善功效和降低毒性,但是由于药物从关节腔中快速清除,结果并未成功。载有MTX的聚合物微球可提供控释药物递送系统,以维持关节腔内MTX的有效浓度。目的是开发载有MTX的微球,并确定兔关节内注射后的体内生物分布和功效。由平均分子量为2000 g / mol的聚(L-乳酸)制造的负载MTX的聚(L-乳酸)微球(尺寸范围为33-110微米)(PLLA2k)在兔关节中表现出良好的耐受性。载有MTX的PLLA2k微球的体外药物释放曲线显示出一个快速的爆发期,在5天内释放了超过50%的药物,随后是一个缓慢的释放期。在健康兔子中关节内注射1.5 mg和10 mg的MTX溶液或载有MTX的微球(33-110微米)后,MTX的药代动力学进行了研究。关节内注射后15 min(tmax)血浆浓度达到峰值,并且注射MTX溶液的兔子的最大血浆浓度(Cmax)比注射MTX微球的兔子高5倍。{09}注射的MTX约70%在关节内注射后24小时,在注射MTX溶液的兔子的尿中排泄了该剂量,而在注射MTX微球的兔子的尿中仅排泄了12%的剂量。使用抗原诱导的关节炎兔模型评估关节内载有MTX的PLLA2k微球(33-110微米)或MTX溶液的体内功效。通过观察类似于类风湿关节炎的组织病理学特征,成功地在兔关节中诱发了关节炎。根据膝关节的肿胀程度和对该疾病的病理特征评分的系统,与磷酸盐缓冲液(对照)动物相比,MTX溶液和微球治疗组之间无显着差异。对载有MTX的微球治疗缺乏治疗反应的原因可能是所诱发疾病的严重性和观察期不足。负载MTX的PLLA2k微球在兔膝关节中显示出良好的耐受性,并在关节内注射后提供了可控制的MTX局部递送至关节腔。

著录项

  • 作者

    Liang, Sanching Linda.;

  • 作者单位

    The University of British Columbia (Canada).;

  • 授予单位 The University of British Columbia (Canada).;
  • 学科 Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2006
  • 页码 268 p.
  • 总页数 268
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药剂学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号